Why the study?
Does compliance with heart failure performance measures (HFPMs) reduce short-term mortality and readmissions in patients with heart failure?
Does compliance with heart failure performance measures (HFPMs) reduce short-term mortality and readmissions in patients with heart failure?
Adherence to a composite of heart failure performance measures is associated with a reduction in 6-month all-cause readmissions, though it does not significantly impact short-term mortality.
BACKGROUND: To determine whether compliance with heart failure performance measures (HFPMs) is associated with short-term outcome benefit. METHODS: In a cohort study, 194 patients satisfying all the HFPMs for which they were eligible were compared with 206 controls. Over 6 months, time to death and first all-cause readmission data were collected. Data were adjusted for differences in comorbidities, medications, and demographics in a multivariate model. RESULTS: There was no difference in 6-month mortality between the 2 groups. Adjusted time to death or all-cause hospitalization (hazard ratio [HR], 0.75; 95% confidence interval [CI], 0.58-0.97; P = .03) and all-cause hospitalization (HR, 0.74; 95% CI, 0.57-0.97; P = .03) were shorter for the study group compared with control, whereas there was no difference in time to death (HR, 0.86; 95% CI, 0.66-1.11; P = .24). CONCLUSIONS: Adherence to a composite of HFPM appears to be related to a reduction in all-cause readmissions for patients with HF but not short-term mortality.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: